Share
Four University of California medical centers — San Diego, San Francisco, Irvine, and Davis — have begun recruiting participants for a Phase III clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir.
Remdesivir Is an Antiviral Drug
Remdesivir belongs to a class of antiviral drugs that inhibit RNA-dependent RNA polymerase, an enzyme necessary for some RNA viruses like SARS-CoV-2 to replicate.
Inhibiting the enzyme may prevent viral replication in infected cells.
440 Participants in Trial
The trial is projected to run to April 1, 2023, and will ultimately involve an estimated 440 participants. It is sponsored by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health.
The UC trial will begin with a small group of participants. All must be hospitalized patients with diagnosed COVID-19. All must be patients of UC San Diego Health or other participating UC health systems.
Research is Evolving and Fluid
“Due to the evolving, fluid nature of this research and what we’re learning daily about the virus and about improving treatment, the trial is designed to be adaptive, to shift investigation to the most promising avenues,” said co-principal investigator Constance Benson, MD, professor of medicine at UC San Diego School of Medicine and an infectious disease specialist at UC San Diego Health.
RELATED TOPICS:
Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report
16 hours ago
Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media
17 hours ago
Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say
17 hours ago
Trump Orders Nuclear Submarines Moved Near Russia
18 hours ago
Ghislaine Maxwell Moved From Florida Prison to Lower-Security Facility
19 hours ago
Trump Escalates Trade War With Canada Following Palestine Stance
19 hours ago
Valley Crime Stoppers’ Most Wanted Person of the Day: Scott Oscar Whitehead
20 hours ago
US Judges Speak Out About Death Threats, ‘Swattings,’ and ‘Pizza Doxings’
14 hours ago
Categories

US Judges Speak Out About Death Threats, ‘Swattings,’ and ‘Pizza Doxings’

Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say

Trump Orders Nuclear Submarines Moved Near Russia
